pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
UBT-48128
Diabetes
The United Laboratories International Holdings Ltd
0
catalysts
Phase 1
UBVV-111
Chronic Lymphocytic Leukemia (CLL)
Umoja BioPharma Inc
0
catalysts
Phase 1
UBX-303
Diffuse Large B-Cell Lymphoma
Ubix Therapeutics Inc
0
catalysts
Phase 3
UGN-103
← prev
page 170 of 271
next →
131
Pain
89
Neurology
1
mitomycin
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$URGN
UroGen Pharma Ltd.
0
catalysts
Phase 3
UGN-104
mitomycin
Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
$URGN
UroGen Pharma Ltd.
0
catalysts
ULTIVA
ULTIVA (REMIFENTANIL HYDROCHLORIDE)
Mylan Institutional Inc
0
catalysts
ULTRA-TECHNEKOW V4
ULTRA-TECHNEKOW V4 (TECHNETIUM TC-99M)
CURIUM
0
catalysts
ULTRATAG RBC
ULTRATAG RBC (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M RED BLOOD CELLS)
CURIUM
0
catalysts
ULTRAVIST
ULTRAVIST (IOPROMIDE)
BAYER HLTHCARE
0
catalysts
Phase 2
UNDC-005
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Myra EB Systems LLC
0
catalysts
UNLOXCYT
UNLOXCYT (COSIBELIMAB-IPDL)
1. INDICATIONS AND USAGE UNLOXCYT is indicated for the treatment of adults wi…
Programmed cell death 1 ligand 1
$CCCC
C4 Therapeutics, Inc.
0
catalysts
Marketed
Ultravate
Ultravate (halobetasol propionate)
Plaque Psoriasis (Psoriasis Vulgaris)
Sun Pharmaceutical Industries Ltd
0
catalysts
Phase 2
Umedaptanib Pegol
Wet (Neovascular / Exudative) Macular Degeneration
Ribomic Inc
0
catalysts
Preclinical
Undisclosed
Solid Tumor
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
Up-284
Glioblastoma Multiforme (GBM)
Up Therapeutics LLC
0
catalysts
Preclinical
Urinary Tract Infections Program
Urinary Tract Infections
$BNTX
BioNTech SE
0
catalysts
Phase 2
V-181
Dengue Fever
$MRK
Merck & Co., Inc.
0
catalysts
VABYSMO
VABYSMO (FARICIMAB-SVOA)
Genentech Inc
0
catalysts
Preclinical
VAC-23
VAC23
Melanoma
Trekka Therapeutics LLC
0
catalysts
Phase 1
VAC-85135
Essential Thrombocythemia
$JNJ
JOHNSON & JOHNSON
0
catalysts
VAFSEO
VAFSEO (VADADUSTAT)
1 INDICATIONS AND USAGE VAFSEO is indicated for the treatment of anemia due t…
Egl nine homolog 1
Prolyl hydroxylase EGLN2
$AKBA
Akebia Therapeutics, Inc.
0
catalysts
VALACYCLOVIR
VALACYCLOVIR (VALACYCLOVIR)
SUN PHARM INDS LTD
0
catalysts
VALGANCICLOVIR
VALGANCICLOVIR (VALGANCICLOVIR)
Ajanta Pharma Ltd
0
catalysts
VALSARTAN AND HYDROCHLOROTHIAZIDE
VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
ZYDUS LIFESCIENCES
0
catalysts
Marketed
VALTREX
VALTREX (VALACYCLOVIR HYDROCHLORIDE)
Chicken Pox
GlaxoSmithKline LLC
0
catalysts
VANFLYTA
VANFLYTA (QUIZARTINIB DIHYDROCHLORIDE)
Daiichi Sankyo Co Ltd
0
catalysts
VANRAFIA
VANRAFIA (ATRASENTAN HYDROCHLORIDE)
1 INDICATIONS AND USAGE VANRAFIA is indicated to reduce proteinuria in adults…
Endothelin-1 receptor
$NVS
NOVARTIS AG
0
catalysts
Phase 1
VAR-200
Focal Segmental Glomerulosclerosis (FSGS)
$ZVSA
ZyVersa Therapeutics, Inc.
0
catalysts
VARIBAR THIN LIQUID
VARIBAR THIN LIQUID (BARIUM SULFATE)
BRACCO
0
catalysts
VAROPHEN
VAROPHEN (DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE)
APOTEX
0
catalysts
